Adagio Medical Holdings, Inc

Stage 4 · Declining · week 22

As of Oct 22, 2026, Adagio Medical Holdings is in Stage 4, the downtrend phase, now in week 22 (since May 21, 2026). It closed at $0.11, 93.2% below its 52-week high and below its 200-day average, which is falling.

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. More about the company

$0.11

-2.29% today

$3.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ADGM early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-08-01 → 2026-10-22

S? 41w

S1 14w

S2 11w

S1 15w

S4 22w

2024-08-012026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 41w → S1 14w → S2 11w → S3 4w → S4 9w → S1 15w → S4 22w current

Total tracked: 115 weeks across 7 stage runs.

ADGM among Medical Devices122nd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…122	ADGMAdagio Medical Holdings, Inc	Stage 4 · wk 22	6	−51.3%

vs 52W High

-93.2%

$0.09 lo$1.63 hi

93.2% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 22

1w13w26w

Week 22, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-85.7%

200 DMA: $0.78 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.08x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-51.3%

-77.0%

-92.6%

YTD

-89.7%

-92.2%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 22 · Vol 0.08x

2026-10-21S4

Wk 22 · Vol 0.34x

2026-10-20S4

Wk 21 · Vol 0.35x

2026-10-19S4

Wk 21 · Vol 1.49x

2026-10-16S4

Wk 21 · Vol 0.28x

2026-10-15S4

Wk 21 · Vol 12.54x

2026-10-14S4

Wk 21 · Vol 0.28x

2026-10-13S4

Wk 20 · Vol 0.07x

2026-10-12S4

Wk 20 · Vol 0.11x

2026-10-09S4

Wk 20 · Vol 0.06x

2026-10-08S4

Wk 20 · Vol 0.13x

2026-10-07S4

Wk 20 · Vol 0.14x

Moving averages & range

50 DMA

$0.38

200 DMA

$0.78

52W High

$1.63

52W Low

$0.09

5D Low

$0.10

Resistance levels (recent highs)

20d High

$0.20

60d High

$0.80

120d High

$0.98

250d High

$1.63

Next resistance

+75.7%

to 20d High

ROE

-657.8%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -5.8

Adagio Medical Holdings: quick answers

What stage is Adagio Medical Holdings in?

As of Oct 22, 2026, Adagio Medical Holdings (ADGM) is in Stage 4, the downtrend phase. It entered Stage 4 on May 21, 2026 and is in week 22. What the four stages mean

Is Adagio Medical Holdings in an uptrend?

No. Adagio Medical Holdings is in a Stage 4 downtrend. It trades 85.7% below its 200-day average, which is falling.

How far is Adagio Medical Holdings from its 52-week high?

Adagio Medical Holdings closed at $0.11 on Oct 22, 2026, 93.2% below its 52-week high of $1.63. Its 52-week low is $0.09.

How has Adagio Medical Holdings performed over the past year?

As of Oct 22, 2026, Adagio Medical Holdings is down 92.2% over the past year and down 89.7% so far in 2026.

Which sector and industry is Adagio Medical Holdings in?

Adagio Medical Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.